Skip to main content
. 2015 Sep;5(3):547–556. doi: 10.1086/682427

Figure 2.

Figure 2

Effect of ranolazine on functional status in pulmonary arterial hypertension. Changes in functional parameters including mean World Health Organization functional class, 6-minute walk distance, exercise capacity, and exercise time from baseline to after 3 months of ranolazine therapy.